Skip Navigation

About Cheryl

Cheryl's practice focuses on mergers and acquisitions, divestitures, private equity investments, joint ventures and corporate reorganizations. She has substantial experience in negotiating and advising in connection with acquisitions and divestitures for both public and private companies, with a particular focus in the financial services, insurance and life sciences industries.

Cheryl also has extensive experience in assisting clients in the life sciences and insurance industries in connection with their commercial outsourcing arrangements. In the life sciences area, she routinely acts for manufacturers and distributors of pharmaceutical products and medical devices in connection with their product licensing, marketing, distribution, and supply arrangements. For financial institutions and insurers, she regularly advises in connection with the implementation of insurance programs and national and international reinsurance arrangements.

Cheryl is a member of the Blakes Executive Committee.

Select Experience

Recent representative matters include acting for:

Financial Services/Insurance

  • Royal Bank of Canada on its C$13.5-billion acquisition of HSBC Bank of Canada

  • Ontario Teachers Pension Plan Board on its acquisition of HomeQ Corporation, the parent company of Home Equity Bank

  • Pacific Equity Partners on its C$165-million divestiture of AST Investor Services Inc. (Canada) and AST Trust Company (Canada) to the TMX Group Limited

  • Intact Financial Corporation on its C$1-billion acquisition of The Guarantee Company of North America and MGA Frank Cowan Company Limited

  • Republic Financial Holdings Limited on its acquisition of Scotiabank's Caribbean banking operations

  • Transamerica/Aegon on the C$600-million sale of its business in Canada to Wilton Re/CPPIB

  • VRG Capital in connection with its backing of a management buy-out of Jones Brown Inc. and the subsequent sale of Jones Brown to Arthur J. Gallagher & Co.

  • Three leading Canadian trust companies in connection with the divestitures of their corporate trust and stock transfer businesses

  • Intact Financial Corporation with its C$2.6-billion acquisition of the Canadian insurance businesses of AXA S.A

Life Sciences

  • GlaxoSmithKline Biologicals S.A. on its advanced purchase agreement with the Government of Canada for the supply of adjuvanted COVID-19 vaccines in collaboration with Sanofi

  • GlaxoSmithKline Biologicals S.A. on its collaboration agreement with Medicago Inc. to develop, manufacture and distribute a COVID-19 candidate vaccine

  • GlaxoSmithKline Inc. on its supply agreement to provide the Government of Canada with its COVID-19 monoclonal antibody therapy

  • Catalent Pharma Solutions Ltd., as Canadian counsel, on its purchase of all of the shares of Accucaps Industries Ltd. from Apotex Holdings Inc.

  • A large multinational provider of electronic and electronical products, systems and solutions on the Canadian aspects of a multi-billion dollar sale of their global medical device business

  • A private equity firm in connection with its acquisition and continuing consolidation of specialist dental and orthodontist practices across Canada

  • GlaxoSmithKline plc, as Canadian counsel, in connection with the Canadian aspects of its major three-part inter-conditional transaction with Novartis AG involving its vaccines, oncology and consumer healthcare businesses (this deal was named Matter of the Year in the 2015 GCR Awards)

Other Recent M&A

  • Equinix, Inc. on its C$1.04-billion acquisition of 25 data-centre facilities across Canada from BCE Inc.

  • Maple Leaf Foods on its acquisition of LightLife Foods

  • Maple Leaf Foods Inc. on the sale of its animal nutrition and Rothsay businesses

Awards & Recognition

Cheryl is recognized in:

  • The Canadian Legal Lexpert Directory (2021–2024: Corporate Mid-Market; 2022, 2024: Corporate Commercial Law; 2022–2024: Life Sciences & Health, Private Equity; 2021–2022, 2024: Mergers & Acquisitions)

  • Thomson Reuters Stand-out Lawyers – Independently Rated Lawyers – 2021, 2024 (As nominated by senior in-house counsel)

  • The Best Lawyers in Canada 2024 (Health Care Law, Mergers and Acquisitions Law)

  • Chambers Canada: Canada’s Leading Lawyers for Business 2024 (Life Sciences: Corporate/Commercial)

  • IFLR1000: The Guide to the World's Leading Financial and Corporate Law Firms 2023 (M&A)

  • Chambers Canada: Canada’s Leading Lawyers for Business – 2022–2023 (Life Sciences: Corporate/Commercial)

  • The Best Lawyers in Canada – 2021–2023 (Health Care Law)

  • IFLR1000: The Guide to the World's Leading Financial and Corporate Law Firms 2022 (M&A)

  • Chambers Canada: Canada’s Leading Lawyers for Business – 2020–2021 (Life Sciences)

  • Who's Who Legal: Life Sciences 2016

  • The Lexpert Guide to the Leading US/Canada Cross-Border Corporate Lawyers in Canada 2015 (Corporate Lawyers to Watch)


Admitted to the Ontario Bar – 2000
LLB, University of Western Ontario – 1998

More insights

Save Profile

Select sections to customize your PDF